Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 566 | 2023 |
Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 80 | 2023 |
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 28 | 2024 |
Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective N Zafari, M Velayati, M Fahim, M Maftouh, G Pourali, M Khazaei, M Nassiri, ... Life Sciences 305, 120760, 2022 | 24 | 2022 |
The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer G Pourali, AM Ahmadzade, M Arastonejad, R Pourali, D Kazemi, ... Molecular and Cellular Biochemistry, 1-13, 2023 | 9 | 2023 |
Metabolic pathways regulating colorectal cancer: A potential therapeutic approach N Zafari, M Velayati, S Damavandi, G Pourali, MG Mobarhan, M Nassiri, ... Current Pharmaceutical Design 28 (36), 2995-3009, 2022 | 9 | 2022 |
The potential diagnostic and prognostic value of circulating MicroRNAs in the assessment of patients with prostate cancer: rational and progress E Samami, G Pourali, M Arabpour, A Fanipakdel, S Shahidsales, ... Frontiers in Oncology 11, 716831, 2022 | 9 | 2022 |
Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: results from the Global Burden of Disease Study 2021 ME Moberg, EB Hamilton, SM Zeng, D Bryazka, JT Zhao, R Feldman, ... The Lancet Public Health 8 (11), e839-e849, 2023 | 8 | 2023 |
Identification of potential biomarkers in stomach adenocarcinoma using machine learning approaches E Nazari, G Pourali, M Khazaei, A Asadnia, M Dashtiahangar, R Mohit, ... Current Bioinformatics 18 (4), 320-333, 2023 | 8 | 2023 |
MicroRNA and exosome in retinal-related diseases: Their roles in the pathogenesis and diagnosis A Salmaninejad, G Pourali, A Shahini, H Darabi, S Azhdari Combinatorial chemistry & high throughput screening 25 (2), 211-228, 2022 | 7 | 2022 |
Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer F Khojasteh-Leylakoohi, R Mohit, N Khalili-Tanha, A Asadnia, H Naderi, ... Scientific reports 13 (1), 16678, 2023 | 5 | 2023 |
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 4 | 2024 |
Circulating tumor cells and cell-free nucleic acids as biomarkers in colorectal cancer G Pourali, G Khalili-Tanha, E Nazari, M Maftooh, M Nassiri, ... Current Pharmaceutical Design 29 (10), 748-765, 2023 | 4 | 2023 |
Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019 SA Nejadghaderi, S Saeedi Moghaddam, M Keykhaei, P Shobeiri, ... Frontiers in Endocrinology 14, 1115833, 2023 | 4 | 2023 |
Microbiome as a biomarker and therapeutic target in pancreatic cancer G Pourali, D Kazemi, AS Chadeganipour, M Arastonejad, SN Kashani, ... BMC microbiology 24 (1), 16, 2024 | 3 | 2024 |
Association of a genetic variant in chromosome 9p21 with increased risk of developing cervical cancer M Atabati, R Saber, P Malakuti, G Pourali, M Heydari-Majd, P Safavi, ... Current Cancer Therapy Reviews 19 (4), 358-362, 2023 | 3 | 2023 |
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities G Pourali, N Zafari, H Fiuji, J Batra, E Nazari, M Khazaei, SM Hassanian, ... Cytokine & Growth Factor Reviews, 2023 | 3 | 2023 |
Probiotics as a therapeutic approach in colorectal cancer. N Rahmani, G Pourali, N Hosseini, H Fiuji, M Maftooh, SM Hassanian, ... Current Cancer Drug Targets, 2023 | 2 | 2023 |
Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study R Sharma, H Abbastabar, DM Abdulah, H Abidi, H Abolhassani, ... The Lancet Regional Health-Southeast Asia 21, 2024 | 1 | 2024 |
Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer G Pourali, N Zafari, M Velayati, S Mehrabadi, M Maftooh, SM Hassanian, ... Current Drug Targets 24 (17), 1335-1345, 2023 | 1 | 2023 |